Exelixis narrows 2025 revenue guidance to $2.3B–$2.35B amid accelerated GI franchise expansion and new pivotal trials (NASDAQ:EXEL)

Group 1 - The article does not provide any relevant content regarding the company or industry [1]

Exelixis narrows 2025 revenue guidance to $2.3B–$2.35B amid accelerated GI franchise expansion and new pivotal trials (NASDAQ:EXEL) - Reportify